SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125816
Filing Date
2020-11-16
Accepted
2020-11-16 16:15:58
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029889-1_10q.htm 10-Q 672539
2 EXHIBIT 31.1 tm2029889d1_ex31-1.htm EX-31.1 9382
3 EXHIBIT 31.2 tm2029889d1_ex31-2.htm EX-31.2 9315
4 EXHIBIT 32.1 tm2029889d1_ex32-1.htm EX-32.1 4883
  Complete submission text file 0001104659-20-125816.txt   5851498

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20200930.xml EX-101.INS 1543805
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20200930.xsd EX-101.SCH 46880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20200930_cal.xml EX-101.CAL 46548
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20200930_def.xml EX-101.DEF 179563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20200930_lab.xml EX-101.LAB 339369
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20200930_pre.xml EX-101.PRE 327410
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 201317114
SIC: 2834 Pharmaceutical Preparations